Back to Search
Start Over
Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer
- Source :
- Journal of Virus Eradication, Vol 3, Iss, Pp 55-56 (2017)
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
Epidemiology
medicine.medical_treatment
Immunology
Human immunodeficiency virus (HIV)
Pembrolizumab
medicine.disease_cause
Microbiology
03 medical and health sciences
Cancer immunotherapy
Virology
Internal medicine
Interim
medicine
In patient
business.industry
Public Health, Environmental and Occupational Health
Cancer
medicine.disease
QR1-502
030104 developmental biology
Infectious Diseases
Public aspects of medicine
RA1-1270
business
Subjects
Details
- ISSN :
- 20556640
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of Virus Eradication
- Accession number :
- edsair.doi.dedup.....81cdb03c9f5da4fd3b467a816181d144
- Full Text :
- https://doi.org/10.1016/s2055-6640(20)30567-7